Brent Zanke
Oprichter bij ArcticDX, Inc.
Profiel
Brent Zanke is the founder of ArcticDX, Inc. where he holds the title of Director starting in 2006.
Dr. Zanke is also the founder of CTRL Therapeutics, Inc. Dr. Zanke's former job was as Director at Cross Cancer Institute.
Dr. Zanke earned a doctorate degree from the University of Toronto in 1993 and another doctorate degree from the University of Manitoba in 1983.
Actieve functies van Brent Zanke
| Bedrijven | Functie | Begin |
|---|---|---|
ArcticDX, Inc.
 ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Oprichter | 10-06-2010 |
Eerdere bekende functies van Brent Zanke
| Bedrijven | Functie | Einde |
|---|---|---|
CTRL Therapeutics, Inc.
 CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Algemeen Directeur | - |
| Cross Cancer Institute | Directeur/Bestuurslid | - |
Opleiding van Brent Zanke
| University of Manitoba | Doctorate Degree |
| University of Toronto | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
ArcticDX, Inc.
ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Health Services |
| Cross Cancer Institute | |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Health Technology |
